Drug recall · January 20, 2016
DEXTROAMPHETAMINE SACCHARATE recall
Why: Failed Impurities/Degradation Specifications: High out of specification test result for impurities during stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE Tablets (Mixed Salts of a Single Entity Amphetamine Product), 10 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-0972-02, UPC 3 0555-0972-02 0.
- Lots / codes
Lot #: 34015516A, Exp 05/16
- Quantity
- 9,717 bottles
- Company
- Teva Pharmaceuticals USA, North Wales, PA
- Distribution
- Nationwide
- Initiated
- November 12, 2015 · Voluntary: Firm initiated
- Classified
- January 11, 2016
- Reported
- January 20, 2016
- Ended
- November 1, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.